Is ImmunoGen, Inc. (IMGN) a Winner in the Biotechnology Industry?

Wednesday, December 01, 2021 10:16 AM | InvestorsObserver Analysts

Mentioned in this article

Is ImmunoGen, Inc. (IMGN) a Winner in the Biotechnology Industry?

A rating of 92 puts ImmunoGen, Inc. (IMGN) near the top of the Biotechnology industry according to InvestorsObserver. ImmunoGen, Inc.'s score of 92 means it scores higher than 92% of stocks in the industry. ImmunoGen, Inc. also received an overall rating of 61, putting it above 61% of all stocks. Biotechnology is ranked 80 out of the 148 industries.

IMGN has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on IMGN!

See Full IMGN Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With ImmunoGen, Inc. Stock Today?

ImmunoGen, Inc. (IMGN) stock is trading at $7.07 as of 10:16 AM on Wednesday, Dec 1, a gain of $0.90, or 14.51% from the previous closing price of $6.17. The stock has traded between $6.13 and $7.10 so far today. Volume today is 4,478,290 compared to average volume of 3,673,030. Click Here to get the full Stock Report for ImmunoGen, Inc. stock.